The Globe and Mail reports in its Tuesday, Nov. 14, edition that RBC Capital Markets analyst Andrew Wong reinstated coverage of Cameco with an "outperform" recommendation and $70 target following the close of the Westinghouse transaction. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $66.33. Mr. Wong says in a note: "We believe Cameco is set to become a leading player in a nuclear industry experiencing a rebirth amid the global energy transition. We see the Westinghouse acquisition and future investments as the path to creating a full-service nuclear company that can compete globally and benefit from increased investment into the sector. Together with tight uranium markets supporting stronger prices, we think Cameco could more than double EBITDA by 2035."